Real time Form 13D and 13G transaction reports:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Due to inconsistent filing format, it is highly recommended that you read the orignal filing form.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
| Reported DateTime | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | Filing |
| 2024-11-14 4:25 pm Sale | 13G | Fulcrum Therapeutics Inc. FULC | SUVRETTA CAPITAL MANAGEMENT LLC | 1,182,791 2.200% | -4,336,090 (-78.57%) | View |
| 2024-11-14 06:15 am Sale | 13G | Fulcrum Therapeutics Inc. FULC | RTW INVESTMENTS LP | 0 0.000% | -5,469,956 (Position Closed) | View |
| 2024-11-12 3:51 pm Unchanged | 13G | Fulcrum Therapeutics Inc. FULC | VANGUARD GROUP INC | 3,274,592 5.240% | 0 (Unchanged) | View |
| 2024-11-08 2:17 pm Unchanged | 13G | Fulcrum Therapeutics Inc. FULC | BlackRock Inc. | 5,706,620 9.100% | 0 (Unchanged) | View |
| 2024-11-04 11:49 am Purchase | 13G | Fulcrum Therapeutics Inc. FULC | VANGUARD GROUP INC | 3,274,592 5.240% | 3,274,592 (New Position) | View |
| 2024-10-21 4:11 pm Purchase | 13G | Fulcrum Therapeutics Inc. FULC | BlackRock Inc. | 5,706,620 9.100% | 5,706,620 (New Position) | View |
| 2024-10-07 11:37 am Sale | 13G | Fulcrum Therapeutics Inc. FULC | FMR LLC | 1,724,014 2.762% | -3,960,601 (-69.67%) | View |
| 2024-09-20 4:21 pm Purchase | 13G | Fulcrum Therapeutics Inc. FULC | TCG Crossover GP II LLC | 5,000,000 9.400% | 5,000,000 (New Position) | View |
| 2024-09-16 8:21 pm Purchase | 13G | Fulcrum Therapeutics Inc. FULC | RA CAPITAL MANAGEMENT L.P. | 10,229,099 19.300% | 4,684,883 (+84.50%) | View |
| 2024-08-23 4:16 pm Sale | 13G | Fulcrum Therapeutics Inc. FULC | RA CAPITAL MANAGEMENT L.P. | 5,544,216 9.990% | -6,065,488 (-52.24%) | View |
| 2024-02-14 5:01 pm Purchase | 13G | Fulcrum Therapeutics Inc. FULC | RA CAPITAL MANAGEMENT L.P. | 11,609,704 18.800% | 1,923,076 (+19.85%) | View |
| 2024-02-14 4:19 pm Unchanged | 13G | Fulcrum Therapeutics Inc. FULC | Third Rock Ventures III L.P. | 2,343,154 3.800% | 0 (Unchanged) | View |
| 2024-02-14 07:53 am Purchase | 13G | Fulcrum Therapeutics Inc. FULC | RTW INVESTMENTS LP | 5,469,956 8.800% | 476,677 (+9.55%) | View |
| 2024-02-13 12:08 pm Purchase | 13G | Fulcrum Therapeutics Inc. FULC | SUVRETTA CAPITAL MANAGEMENT LLC | 5,518,881 8.900% | 1,244,078 (+29.10%) | View |
| 2024-02-09 09:03 am Purchase | 13G | Fulcrum Therapeutics Inc. FULC | FMR LLC | 5,684,615 9.195% | 450,890 (+8.62%) | View |
| 2024-02-07 07:44 am Sale | 13G | Fulcrum Therapeutics Inc. FULC | ADAGE CAPITAL PARTNERS GP L.L.C. | 1,506,422 2.440% | -1,964,125 (-56.59%) | View |
| 2023-07-07 4:35 pm Sale | 13G | Fulcrum Therapeutics Inc. FULC | BlackRock Inc. BLK | 1,514,425 2.500% | -1,754,566 (-53.67%) | View |
| 2023-03-06 4:40 pm Purchase | 13G | Fulcrum Therapeutics Inc. FULC | ADAGE CAPITAL PARTNERS GP L.L.C. | 3,470,547 5.630% | 2,350,547 (+209.87%) | View |
| 2023-02-14 4:15 pm Sale | 13G | Fulcrum Therapeutics Inc. FULC | Point72 Asset Management L.P. | 30,702 0.100% | -2,037,172 (-98.52%) | View |
| 2023-02-14 4:07 pm Sale | 13G | Fulcrum Therapeutics Inc. FULC | Third Rock Ventures III L.P. | 2,343,154 4.500% | -1,703,271 (-42.09%) | View |